ES2172882T3 - Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos. - Google Patents
Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos.Info
- Publication number
- ES2172882T3 ES2172882T3 ES98913997T ES98913997T ES2172882T3 ES 2172882 T3 ES2172882 T3 ES 2172882T3 ES 98913997 T ES98913997 T ES 98913997T ES 98913997 T ES98913997 T ES 98913997T ES 2172882 T3 ES2172882 T3 ES 2172882T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- compound
- preparation
- indazol
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical group C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- LCHWKMAWSZDQRD-UHFFFAOYSA-N silylformonitrile Chemical compound [SiH3]C#N LCHWKMAWSZDQRD-UHFFFAOYSA-N 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- -1 -OR4 Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Un procedimiento para la preparación de un compuesto de fórmula o una sal farmaceúticamente aceptable de dicho compuesto, en la que: R es alquilo (C1-C10) o -(CH2)n(fenilo), en el que n es un número entero que va de 0 a 2, y en el que dichos grupos R están opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados entre cloro, fluoro, alcoxi (C1-C6) y trifluorometilo; R1 es alquilo (C1-C10), alquenilo (C2-C6) o fenilo, en el que dichos grupos R1 están opcionalmente sustituidos con 1 a 3 sustituyentes independientemente seleccionados entre trifluorometilo, cloro y fluoro; R2 es H, -C(Y)R4, -C(O)OR4, -C(Y)NR5R4, - C(Y)NR5OR4, o CN; R3 es H, alquilo (C1-C6) opcionalmente sustituido con hidroxi, -OR4, -CN, -C(Y)R4, -C(O)OR4, -C(Y)NR4R5, - C(Y)NR4OR5, -NR4OR5 o NR4R5; o R2 y R3 se unen formando =O; cada R4 y R5 es independientemente H o alquilo (C1- C6); y cada Y es independientemente O o S; el cual comprende el tratamiento de un compuesto de fórmula o una sal de dicho compuesto, en la que R, R1, R2 y R3 son lo definido anteriormente, con un ácido de Lewis y cianuro de tri-(aril C6-C10)sililo o cianuro de tri- (alquil C1-C6)sililo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4685897P | 1997-05-08 | 1997-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2172882T3 true ES2172882T3 (es) | 2002-10-01 |
Family
ID=21945777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98913997T Expired - Lifetime ES2172882T3 (es) | 1997-05-08 | 1998-04-28 | Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6011159A (es) |
| EP (1) | EP0983249B1 (es) |
| JP (1) | JP3399546B2 (es) |
| AR (2) | AR015648A1 (es) |
| AT (1) | ATE214373T1 (es) |
| AU (1) | AU6849798A (es) |
| DE (1) | DE69804212T2 (es) |
| DK (1) | DK0983249T3 (es) |
| ES (1) | ES2172882T3 (es) |
| PT (1) | PT983249E (es) |
| WO (1) | WO1998050367A1 (es) |
| ZA (1) | ZA983842B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2001002304A0 (en) * | 1996-05-03 | 2001-12-31 | Pfizer | Substituted indazole derivatives and related compounds |
| IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
| CN1281441A (zh) * | 1997-11-04 | 2001-01-24 | 辉瑞产品公司 | 以在pde4抑制剂中的儿茶酚的吲唑生物等排物置换为基础的治疗活性化合物 |
| JP2000198734A (ja) * | 1998-12-30 | 2000-07-18 | Pfizer Inc | 胃運動性減弱および関連疾患の治療のための運動性増強薬 |
| KR100423899B1 (ko) * | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
| DE102004005172A1 (de) * | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
| US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
| UA88792C2 (ru) * | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
| TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型 |
| EP2021325A2 (en) | 2006-05-09 | 2009-02-11 | AstraZeneca AB | Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL319758A1 (en) | 1994-10-20 | 1997-08-18 | Pfizer | Bicyclic tetrahydropyrasole pyridines and their application as medicines |
| AP2001002304A0 (en) * | 1996-05-03 | 2001-12-31 | Pfizer | Substituted indazole derivatives and related compounds |
-
1998
- 1998-04-28 ES ES98913997T patent/ES2172882T3/es not_active Expired - Lifetime
- 1998-04-28 AU AU68497/98A patent/AU6849798A/en not_active Abandoned
- 1998-04-28 US US09/308,954 patent/US6011159A/en not_active Expired - Fee Related
- 1998-04-28 DK DK98913997T patent/DK0983249T3/da active
- 1998-04-28 DE DE69804212T patent/DE69804212T2/de not_active Expired - Fee Related
- 1998-04-28 WO PCT/IB1998/000647 patent/WO1998050367A1/en not_active Ceased
- 1998-04-28 AT AT98913997T patent/ATE214373T1/de not_active IP Right Cessation
- 1998-04-28 EP EP98913997A patent/EP0983249B1/en not_active Expired - Lifetime
- 1998-04-28 PT PT98913997T patent/PT983249E/pt unknown
- 1998-04-28 JP JP54786398A patent/JP3399546B2/ja not_active Expired - Fee Related
- 1998-05-07 AR ARP980102142A patent/AR015648A1/es unknown
- 1998-05-07 ZA ZA9803842A patent/ZA983842B/xx unknown
-
1999
- 1999-08-03 AR ARP990103861A patent/AR016737A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP0983249A1 (en) | 2000-03-08 |
| PT983249E (pt) | 2002-08-30 |
| EP0983249B1 (en) | 2002-03-13 |
| WO1998050367A1 (en) | 1998-11-12 |
| AR015648A1 (es) | 2001-05-16 |
| AR016737A1 (es) | 2001-07-25 |
| DE69804212T2 (de) | 2002-07-25 |
| JP3399546B2 (ja) | 2003-04-21 |
| US6011159A (en) | 2000-01-04 |
| DE69804212D1 (de) | 2002-04-18 |
| ZA983842B (en) | 1999-11-08 |
| ATE214373T1 (de) | 2002-03-15 |
| AU6849798A (en) | 1998-11-27 |
| DK0983249T3 (da) | 2002-07-08 |
| JP2000513019A (ja) | 2000-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300396I1 (nl) | Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten | |
| NL990025I1 (nl) | Sulfamaatderivaten met anticonvulsieve werking. | |
| EA200101194A1 (ru) | Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств | |
| GR3036688T3 (en) | 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists | |
| EA200500178A1 (ru) | Новые соединения, содержащие их фармацевтические композиции и способы их применеия | |
| RU2004110719A (ru) | Зздабиторы протеаз, расщепляющих за пролином | |
| EA200201244A1 (ru) | Способы получения и промежуточные соединения для получения противораковых соединений | |
| ATE427949T1 (de) | 4-a4-(5-oxo-2,3,5,11a-tetrahydro-5h-pyrrolo a2, 1-cua1,4ubenzodiazepin-8-yloxy)-butyrylaminou-1 - pyrrol-2-carbonsaurealkylesterderivate und verwandte verbindung zur behandlung einer proliferativen erkrankung | |
| MY111314A (en) | Hydroxy - substituted azetidinone compounds useful as hypocholesterolemic agents. | |
| NZ511739A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
| KR950011444A (ko) | 갈란타민 유도체, 이의 제조방법 및 약제로서의 이의 용도 | |
| EA200000847A1 (ru) | Противоопухолевые средства | |
| KR870700628A (ko) | 세파로스포린 중간체를 제조하는 방법 | |
| TNSN91035A1 (fr) | Methode de preparation de derives de furo (3,4-c) pyridine sous forme non-racemique | |
| RU94030470A (ru) | Производные 1-(арилалкиламиноалкил)имидазола, способ их получения, фармацевтическая композиция и способ лечения | |
| NO964103L (no) | Fremgangsmåte for fremstilling av 7-trialkylsilyl-baccatin-III | |
| GB1451912A (en) | 2-1-piperazino-5-oxopyrido-2,3-d-pyridine-6-carboxylic acids their preparation and pharmaceutical compositions thereof | |
| AR015648A1 (es) | Procesos e intermediarios para preparar derivados indazol sustituidos. | |
| AR042444A1 (es) | Metodo para el tratamiento de desordenes del movimiento mediante la utilizacion de acido barbiturico | |
| PT77666A (fr) | Procede de preparation de nouveaux derives de la nitrosouree | |
| AR009086A1 (es) | Un agente inmunosupresor y un compuesto 2,2'-bi-1h pirrol inmunosupresor. | |
| JPS56115749A (en) | Dopa derivative | |
| YU57287A (en) | Process for obtaining estheric derivatives of 1,4-dihydropyridin-3,5-dicarboxylic acid | |
| MXPA04000615A (es) | Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor. | |
| RU92016209A (ru) | Бензофуранилимидазольные производные, способ их получения и терапевтические композиции, содержащие названные производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 983249 Country of ref document: ES |